Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeInspira TechnologiesInspira Technologies and Ben-Gurion University Have Developed a Platform Designed to Prevent...

Inspira Technologies and Ben-Gurion University Have Developed a Platform Designed to Prevent Blood Clotting in Inspira’s ART System

Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW), a breakthrough respiratory medical technology leader, announced today the completion of a development relating to the potential prevention of blood clotting when used in conjunction with its Augmented Respiration Technology (ART) system. The platform is intended to be integrated into the company’s novel ART system, which is currently in its development phase.

The use of anticoagulants for preventing blood clotting during invasive oxygen therapy is standard procedure, despite these drugs posing a high risk. In some cases, anticoagulant medicines increase a person’s risk of life-threatening bleeding in different locations, such as the brain or gastrointestinal tract.

With the potential new platform, created in collaboration with Ben-Gurion University, the company aims to extend the life of oxidizers and potentially prevent blood clotting through its ART system. The research and development process was led by Prof. Joseph Kost, from the Department of Chemical Engineering (Past Dean of the Faculty of Engineering Sciences) at Ben-Gurion University.

Inspira and Prof. Kost have developed and characterized a stable polymeric microbubbles (MBs) platform that releases oxygen on demand. The development process required in-depth research to evaluate the procedures for oxygen engulfment in MBs and observe oxygen release at the required rates. This novel proposed technology will be further developed with the aim to integrate it into the ART system, with the view of making it suitable as a dialysis machine and compatible with other blood oxidation systems.

Prof. Kost describes the platform: “The platform is based on polymeric microbubbles MBs with a gas core, made from a PLGA shell (a biocompatible polymer), synthesized by a modified double emulsion solvent evaporation method”.

Dr. Udi Nussinovitch, MD, Ph.D., Co-Founder and CSO of Inspira, said: “I believe that Inspira is developing groundbreaking technology from a medical device and biotechnological perspective. The joined technologies are intended to use innovative molecular approaches and novel oxygenation methods that have the potential to improve patients’ outcomes.”

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy